NeuroVision Imaging, Inc.

NeuroVision Imaging, Inc. is a digital health and diagnostic imaging company focused on neurology and cognitive health. The company operates two primary business lines: BrainHealth, a comprehensive telehealth platform for cognitive neurology that addresses diagnostic wait times through patient screening, triage, and managed care workflows; and Afina, a proprietary retinal imaging platform with cloud-based AI software designed to identify amyloid signatures in the retina as indicators of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). BrainHealth offers neurologist-designed preventative neurology strategies, brain health education (covering nutrition, sleep, exercise, and mindfulness), lifestyle change coaching via telehealth, APOE genetic testing, biomarker testing, and clinical trial information. Afina leverages advanced imaging and AI analytics to support prediction of CAA and amyloid-related imaging abnormalities (ARIA), the significant side effect associated with emerging Alzheimer's treatments. The platform combines diagnostic innovation with clinical validation through ongoing groundbreaking studies. NeuroVision targets healthcare providers, health systems, and patients seeking accessible, evidence-based neurology diagnostics and preventative care at scale.